Full Year Net Sales of $188.9 million including Proprietary ... cash equivalents, and marketable Securities balance of $56.5 million and no debt 2025 Outlook calls for Revenue of $170 million ...

GrowGeneration Corp. (NASDAQ: GRWG), ("GrowGeneration," "GrowGen" or the "Company"), one of the largest retailers and distributors of specialty hydroponic and organic gardening products in the United ...

As of 2024, Cologuard sales were over $2 billion with ... with over $1 billion of cash and marketable securities on the balance sheet as of 2024. However, with $2.6 billion of convertible notes ...

We concluded the year on a solid financial footing, with a strong cash position and no debt on our balance sheet ... cash equivalents, and marketable securities as of December 31, 2024 ...

"For fiscal 2025, we aim to stabilize and then grow sales ... Balance Sheet and Liquidity As of February 1, 2025, the Company had $46.7 million of cash, cash equivalents and marketable securities ...

A strong balance sheet position including $169 million ... Cash and cash equivalents, restricted cash, short-term deposits and marketable securities were $169 million, with no outstanding debt ...

Docusign, Inc. today announced results for its fourth quarter and fiscal year ended January 31, 2025. Prepared remarks and the news release with the financial results will be accessible on Docusign's ...

Sales of $149.5 million ... adjustment in proportion to the increase in pre-tax income for the period. Balance Sheet and Cash Flow Cash, restricted cash and marketable securities totaled $132.2 ...

It is reducing its balance sheet by £100bil of gilts, up from £80bil in the first year, via a mixture of sales and not reinvesting maturing bonds. The new policy may have the side effect of ...

The cash flow from operations shows a decrease in sales by 12.2% ... tax income for the period. Balance Sheet and Cash Flow Cash, restricted cash and marketable securities totaled $132.2 million ...

American Healthcare REIT, National HealthCare Corp., National Healthcare Properties and The Pennant Group wrapped up last week reporting fourth-quarter and full-year 2024 earnings results to investors ...